{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T19:38:23Z","timestamp":1768160303366,"version":"3.49.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"NIH\/NICHD"},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HSN275201400016C"],"award-info":[{"award-number":["HSN275201400016C"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004856","name":"New York State Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004856","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Research Inc."},{"name":"NIH\/NICHD"},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK067859"],"award-info":[{"award-number":["R01 DK067859"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Pompe disease (PD) is the first lysosomal storage disorder to be added to the Recommended Uniform Screening Panel for newborn screening. This condition has a broad phenotypic spectrum, ranging from an infantile form (IOPD), with severe morbidity and mortality in infancy, to a late-onset form (LOPD) with variable onset and progressive weakness and respiratory failure. Because the prognosis and treatment options are different for IOPD and LOPD, it is important to accurately determine an individual's phenotype. To date, no enzyme assay of acid \u03b1-glucosidase (GAA) has been described that can differentiate IOPD vs LOPD using blood samples.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We incubated 10 \u03bcL leukocyte lysate and 25 \u03bcL GAA substrate and internal standard (IS) assay cocktail for 1 h. The reaction was purified by a liquid\u2013liquid extraction. The extracts were evaporated and reconstituted in 200 \u03bcL methanol and analyzed by LC-MS\/MS for GAA activity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>A 700-fold higher analytical range was observed with the LC-MS\/MS assay compared to the fluorometric method. When GAA-null and GAA-containing fibroblast lysates were mixed, GAA activity could be measured accurately even in the range of 0%\u20131% of normal. The leukocyte GAA activity in IOPD (n = 4) and LOPD (n = 19) was 0.44\u20131.75 nmol \u00b7 h\u22121 \u00b7 mg\u22121 and 2.0\u20136.5 nmol \u00b7 h\u22121 \u00b7 mg\u22121, respectively, with no overlap. The GAA activity of pseudodeficiency patients ranged from 3.0\u201328.1 nmol \u00b7 h\u22121 \u00b7 mg\u22121, showing substantial but incomplete separation from the LOPD group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>This assay allows determination of low residual GAA activity in leukocytes. IOPD, LOPD, and pseudodeficiency patients can be partially differentiated by measuring GAA using blood samples.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1373\/clinchem.2016.259036","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T21:00:22Z","timestamp":1487106022000},"page":"842-851","source":"Crossref","is-referenced-by-count":23,"title":["Liquid Chromatography\u2013Tandem Mass Spectrometry Assay of Leukocyte Acid \u03b1-Glucosidase for Post-Newborn Screening Evaluation of Pompe Disease"],"prefix":"10.1093","volume":"63","author":[{"given":"Na","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyu","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Violante","sequence":"first","affiliation":[{"name":"Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J","family":"Orsini","sequence":"first","affiliation":[{"name":"Laboratory of Human Genetics, New York State Department of Health, Wadsworth Center, Albany, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Caggana","sequence":"first","affiliation":[{"name":"Laboratory of Human Genetics, New York State Department of Health, Wadsworth Center, Albany, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E","family":"Hughes","sequence":"first","affiliation":[{"name":"Laboratory of Human Genetics, New York State Department of Health, Wadsworth Center, Albany, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen","family":"Stevens","sequence":"first","affiliation":[{"name":"Laboratory of Human Genetics, New York State Department of Health, Wadsworth Center, Albany, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"DiAntonio","sequence":"first","affiliation":[{"name":"Laboratory of Human Genetics, New York State Department of Health, Wadsworth Center, Albany, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan","family":"Chieh Liao","sequence":"first","affiliation":[{"name":"Departments of Chemistry and"},{"name":"Biochemistry, University of Washington, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Hong","sequence":"first","affiliation":[{"name":"Departments of Chemistry and"},{"name":"Biochemistry, University of Washington, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farideh","family":"Ghomashchi","sequence":"first","affiliation":[{"name":"Departments of Chemistry and"},{"name":"Biochemistry, University of Washington, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Babu Kumar","sequence":"first","affiliation":[{"name":"Departments of Chemistry and"},{"name":"Biochemistry, University of Washington, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhou","sequence":"first","affiliation":[{"name":"Newborn Screening Translation Research Initiative, National Foundation for the Centers for Disease Control and Prevention, Inc., Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Kornreich","sequence":"first","affiliation":[{"name":"Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Wasserstein","sequence":"first","affiliation":[{"name":"Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H","family":"Gelb","sequence":"first","affiliation":[{"name":"Departments of Chemistry and"},{"name":"Biochemistry, University of Washington, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunli","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,4,1]]},"reference":[{"key":"2020022606064733300_B1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2014.07.014","article-title":"Methods of diagnosis of patients with Pompe disease: data from the Pompe Registry","volume":"113","author":"Kishnani","year":"2014","journal-title":"Mol Genet Metab"},{"key":"2020022606064733300_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.c.31324","article-title":"The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management","volume":"160","author":"Kishnani","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2020022606064733300_B3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J Pediatr"},{"key":"2020022606064733300_B4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet Med"},{"key":"2020022606064733300_B5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pedneo.2013.03.009","article-title":"Pompe disease: early diagnosis and early treatment make a difference","volume":"54","author":"Chien","year":"2013","journal-title":"Pediatr Neonatol"},{"key":"2020022606064733300_B6","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","article-title":"Pompe disease in infants: improving the prognosis by newborn screening and early treatment","volume":"124","author":"Chien","year":"2009","journal-title":"Pediatrics"},{"key":"2020022606064733300_B7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jpeds.2014.10.068","article-title":"Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth","volume":"166","author":"Chien","year":"2015","journal-title":"J Pediatr"},{"key":"2020022606064733300_B8","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1373\/clinchem.2004.035907","article-title":"Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening","volume":"50","author":"Li","year":"2004","journal-title":"Clin Chem"},{"key":"2020022606064733300_B9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ymgme.2012.04.013","article-title":"Algorithm for Pompe disease newborn screening: results from the Taiwan screening program","volume":"106","author":"Chiang","year":"2012","journal-title":"Mol Genet Metab"},{"key":"2020022606064733300_B10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cca.2013.05.001","article-title":"Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform","volume":"424","author":"Sista","year":"2013","journal-title":"Clin Chim Acta"},{"key":"2020022606064733300_B11","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1373\/clinchem.2008.107722","article-title":"Newborn screening for Pompe disease by measuring acid alpha-glucosidase activity using tandem mass spectrometry","volume":"54","author":"Dajnoki","year":"2008","journal-title":"Clin Chem"},{"key":"2020022606064733300_B12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.gim.0000217781.66786.9b","article-title":"Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease","volume":"8","author":"Zhang","year":"2006","journal-title":"Genet Med"},{"key":"2020022606064733300_B13","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1373\/clinchem.2015.242560","article-title":"Tandem mass spectrometry has a larger analytical range than fluorescence assays of lysosomal enzymes: application to newborn screening and diagnosis of mucopolysaccharidoses types II, IVA, and VI","volume":"61","author":"Kumar","year":"2015","journal-title":"Clin Chem"},{"key":"2020022606064733300_B14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ymgme.2005.10.016","article-title":"A new diagnostic assay for glycogen storage disease type II in mixed leukocytes","volume":"88","author":"Okumiya","year":"2006","journal-title":"Mol Genet Metab"},{"key":"2020022606064733300_B15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ajmg.a.36197","article-title":"A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment","volume":"164A","author":"Yang","year":"2014","journal-title":"Am J Med Genet A"},{"key":"2020022606064733300_B16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cccn.2005.05.025","article-title":"Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease","volume":"361","author":"Umapathysivam","year":"2005","journal-title":"Clin Chim Acta"},{"key":"2020022606064733300_B17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mus.21376","article-title":"Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory","volume":"40","author":"Goldstein","year":"2009","journal-title":"Muscle Nerve"},{"key":"2020022606064733300_B18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.nmd.2015.07.002","article-title":"Homozygosity for the common GAA gene splice site mutation c.-32-13T&gt;G in Pompe disease is associated with the classical adult phenotypical spectrum","volume":"25","author":"Musumeci","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"2020022606064733300_B19","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s00415-015-7664-0","article-title":"Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment","volume":"262","author":"Montagnese","year":"2015","journal-title":"J Neurol"},{"key":"2020022606064733300_B20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymgme.2011.01.006","article-title":"Improved assay for differential diagnosis between Pompe disease and acid alpha-glucosidase pseudodeficiency on dried blood spots","volume":"103","author":"Shigeto","year":"2011","journal-title":"Mol Genet Metab"},{"key":"2020022606064733300_B21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ymgme.2009.12.014","article-title":"Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program","volume":"99","author":"Labrousse","year":"2010","journal-title":"Mol Genet Metab"},{"key":"2020022606064733300_B22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ejhg.2008.34","article-title":"p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?","volume":"16","author":"Kroos","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"2020022606064733300_B23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/abio.2000.4838","article-title":"Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease","volume":"287","author":"An","year":"2000","journal-title":"Anal Biochem"},{"key":"2020022606064733300_B24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2005.03.010","article-title":"Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease","volume":"85","author":"An","year":"2005","journal-title":"Mol Genet Metab"},{"key":"2020022606064733300_B25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajmg.c.31320","article-title":"Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques","volume":"160C","author":"Young","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2020022606064733300_B26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/8904_2014_366","article-title":"Baseline urinary glucose tetrasaccharide concentrations in patients with infantile- and late-onset Pompe disease identified by newborn screening","volume":"19","author":"Chien","year":"2015","journal-title":"JIMD Rep"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/63\/4\/842\/32646047\/clinchem0842.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/63\/4\/842\/32646047\/clinchem0842.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T06:17:39Z","timestamp":1582697859000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/63\/4\/842\/5612977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,1]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,1]]},"published-print":{"date-parts":[[2017,4,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2016.259036","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,4,1]]},"published":{"date-parts":[[2017,4,1]]}}}